Last10K.com

Arch Therapeutics, Inc. (ARTH) SEC Filing 10-K Annual report for the fiscal year ending Wednesday, September 30, 2015

SEC Filings

ARTH Registration of Securities

Arch Therapeutics, Inc.

CIK: 1537561 Ticker: ARTH
Document And Entity Information - USD ($)
12 Months Ended
Sep. 30, 2015
Dec. 10, 2015
Mar. 31, 2015
Document Information [Line Items]   
Document Type10-K  
Amendment Flagfalse  
Document Fiscal Year Focus2015  
Entity Registrant NameArch Therapeutics, Inc.  
Entity Central Index Key0001537561  
Entity Well-known Seasoned IssuerNo  
Entity Voluntary FilersNo  
Entity Current Reporting StatusYes  
Trading SymbolARTH  
Document Period End DateSep. 30, 2015  
Document Fiscal Period FocusFY  
Current Fiscal Year End Date--09-30  
Entity Filer CategorySmaller Reporting Company  
Entity Public Float  $ 10,000,000
Entity Common Stock, Shares Outstanding 108,879,552 

View differences made from one year to another to evaluate Arch Therapeutics, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Arch Therapeutics, Inc..

Continue

Assess how Arch Therapeutics, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Arch Therapeutics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2015 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Stockholders' Equity (deficit)
Consolidated Statements Of Operations
Immaterial Corrections To Prior Period Financial Statements (detail)
Immaterial Corrections To Prior Period Financial Statements (statement Of Cash Flow) (detail)
Immaterial Corrections To Prior Period Financial Statements (statement Of Operations) (detail)
2014 Private Placement Financing (tables)
2014 Private Placement Financing - Additional Information (detail)
2015 Restricted Stock
2015 Restricted Stock (tables)
2015 Restricted Stock - Additional Information (detail)
8% Convertible Notes
8% Convertible Notes (tables)
8% Convertible Notes - Additional Information (detail)
Annual License Maintenance Fee Commitments (detail)
Assumptions Used For Derivative Liability (detail)
Coldstream Financing
Coldstream Financing - Additional Information (detail)
Commitments And Contingencies
Commitments And Contingencies (tables)
Commitments And Contingencies - Additional Information (detail)
Derivative Liability For Monte Carlo Simulations (detail)
Description Of Business
Estimated Fair Market Value Of The Derivative Liability (detail)
Fair Value Measurements Using Significant Unobservable Inputs Level 3 (detail)
Immaterial Corrections To Prior Period Financial Statements
Immaterial Corrections To Prior Period Financial Statements (tables)
Immaterial Corrections To Prior Period Financial Statements - Additional Information (detail)
Income Taxes
Income Taxes (detail)
Income Taxes (tables)
Income Taxes - Additional Information (detail)
Note Payable
Note Payable - Additional Information (detail)
Private Placement Financing (2015) - Additional Information (detail)
Private Placement Financing 2014
Private Placement Financing 2015
Property And Equipment
Property And Equipment (detail)
Property And Equipment (tables)
Reclassification Of Prior Year Presentation
Reclassification Of Prior Year Presentation - Additional Information (detail)
Restricted Stock Activity (detail)
Stock Based Compensation Restricted Stock Award Activity (detail)
Stock Based Compensation Stock Option Activity (detail)
Stock-based Compensation
Stock-based Compensation (tables)
Stock-based Compensation - Additional Information (detail)
Subsequent Events
Subsequent Events - Additional Information (detail)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (policies)
Weighted Average Restricted Stock Award (detail 1)
Weighted Average Restricted Stock Award (detail)

Material Contracts, Statements, Certifications & more

Arch Therapeutics, Inc. provided additional information to their SEC Filing as exhibits

Ticker: ARTH
CIK: 1537561
Form Type: 10-K Annual Report
Accession Number: 0001144204-15-070409
Submitted to the SEC: Fri Dec 11 2015 7:30:53 AM EST
Accepted by the SEC: Fri Dec 11 2015
Period: Wednesday, September 30, 2015
Industry: Surgical And Medical Instruments And Apparatus

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/arth/0001144204-15-070409.htm